Concepedia

Xuan Zheng

XZ

Statistics

Publications

1

Citations

16

H-Index

1

Active since

2023

Affiliations

Renji Hospital(Current)

Xuan Zheng is an author at Renji Hospital specializing in programmed death-ligand 1 inhibitors, programmed death-1 inhibition, and cancer immunotherapy.

ORCID

Publications per year

2023–2023

1

Publications

1

Efficacy and safety of anti-PD-1 monotherapy <i>versus</i> anti-PD-1 antibodies plus lenvatinib in patients with advanced hepatocellular carcinoma: a real-world experience

Qingyan Liu, Rong Li, Ling-ling LI et al. · Therapeutic Advances in Medical Oncology · 2023 · 16 citations · Full text

, , +17

1–1 of 1